openPR Logo
Press release

Global Cancer Stem Cell Therapy Market Outlook 2020 Report

05-07-2018 08:33 AM CET | Health & Medicine

Press release from: Kuick Resarch

Global Cancer Stem Cell Therapy Market Outlook 2020 Report

“Global Cancer Stem Cell Therapy Market Outlook 2020” Report Highlight:

* Introduction & Classification of Stem Cells
* Stem Cell Transplants Classification
* Cancer Stem Cell Therapy Mechanism of Action
* Global Cancer Stem Cell Market Analysis
* Global Cancer Stem Cell Clinical Pipeline by Company & Phase
* Global Cancer Stem Cell Clinical Pipeline: 32 Therapies
* Global Cancer Stem Cell Market Dynamics: Challenges & Favorable Parameters
* Global Cancer Stem Cell Market Future Outlook

Download Report Sample Weblink:

https://www.kuickresearch.com/report-Global-Cancer-Stem-Cell-Therapy-Market-Outlook-2020.php

For Report Sample Contact: neeraj@kuickresearch.com

Table of Contents

1. Introduction to Stem Cells



2. Classification of Stem Cells

2.1 Basis of Ability to Differentiate

2.2 Basis of Origin

2.3 Basis of their Source



3. Stem Cell Transplants Classification

3.1 Autologous Stem Cell Transplants

3.2 Allogeneic Stem Cell Transplants

3.3 Syngeneic Stem Cell Transplants



4. Cancer Stem Cell Therapy Mechanism of Action

4.1 Targeting Signaling Pathways

4.1.1 Hedgehog Signaling Pathway

4.1.2 Notch Signaling Pathway

4.1.3 WNT Signaling Pathway

4.2 Targeting Cell Surface Markers

4.3 Targeting miRNA Expression



5. Global Cancer Stem Cell Market Analysis

5.1 Current Market Scenario

5.2 Global Cancer Stem Cell Therapies Pipeline Overview



6. Global Cancer Stem Cell Market Dynamics

6.1 Favorable Market Parameters

6.2 Commercialization Challenges



7. Global Cancer Stem Cell Market Future Outlook



8. Global Cancer Stem Cell Clinical Pipeline by Company & Phase

8.1 Research

8.2 Preclinical

8.3 Clinical

8.4 Phase-I

8.5 Phase-I/II

8.6 Phase-II

8.7 Phase-III



9. Discontinued & No Development of Cancer Stem Cell in Clinical Pipeline by Company & Phase

9.1 Discontinued

9.2 No Development Reported



10. Competitive Landscape

10.1 Aldagen

10.2 Apceth

10.3 Benitec Biopharma

10.4 Celgene Corporation

10.5 Cellonis Biotechnologies

10.6 Caladrius Biosciences

10.7 Commence Bio

10.8 ExCellThera

10.9 Galena Biopharma

10.10 Gamida Cell

10.11 Genexine

10.12 ImmunoCellular Therapeutics

10.13 K-STEMCELL

10.14 Medipost

10.15 Mesoblast

10.16 Novartis

10.17 Nuo Therapeutics

10.18 OncoCyte Corporation

10.19 Pluristem Therapeutics

10.20 ReNeuron

10.21 Sangamo BioSciences

10.22 Takeda

10.23 Vericel Corporation

Figure 1-1: Properties of Stem Cells

Figure 1-2: Utility of Stem Cells

Figure 1-3: Benefits of Stem Cells

Figure 1-4: Limitations of Stem Cells

Figure 2-1: Type of Stem Cells on the Basis of Ability to Differentiate

Figure 2-2: Type of Stem Cells on the Basis of Origin

Figure 2-3: Types of Stem Cells on the Basis of their Source

Figure 2-4: Different Sources of Autologous Stem Cell

Figure 3-1: Different Stem Cell Transplants

Figure 4-1: Development of Resistance in Cancerous Cells against Therapeutics

Figure 4-2: Approach for Developing Cancer Stem Cells based Therapies

Figure 4-3: Targeting Different Signaling Pathways

Figure 4-4: Mechanism of Hedgehog Signaling Pathway

Figure 4-5: Mechanism of Notch Signaling Pathway

Figure 4-6: Mechanism of Wnt Signaling Pathway

Figure 4-7: Mechanism of Cell Surface Marker for Cancer Treatment

Figure 4-8: Mechanism of miRNA Targeting

Figure 5-1: Difference between Autologous & Autogenic HSCTs

Figure 5-2: Global Stem Cell Market Opportunity (US$ Billion), 2015-2020

Figure 5-3: Global Cancer Stem Cell Therapies Pipeline by Phase (%), 2016

Figure 5-4: Global Cancer Stem Cell Therapies Pipeline by Phase (Numbers), 2016

Figure 5-5: Global Cancer Stem Cell Therapies Pipeline by Phase (%), 2016

Figure 5-6: Global Cancer Stem Cell Therapies Pipeline by Phase (Numbers), 2016

Figure 6-1: Global Cancer Stem Cell Market Favorable Parameters

Figure 6-2: Global Cancer Stem Cell Market Commercialization Challenges

Figure 10-1: Benitec Biopharma - Clinical Pipeline

Figure 10-2: Celgene - Clinical Pipeline

Figure 10-3: Caladrius - Clinical Pipeline

Figure 10-4: Commence Bio - Clinical Pipeline

Figure 10-5: Galena Biopharma - Clinical Pipeline

Figure 10-6: Gamida Cell - Clinical Pipeline

Figure 10-7: Genexie - Clinical Pipeline

Figure 10-8: ImmunoCellular Therapeutics - Clinical Pipeline

Figure 10-9: Mesoblast - Clinical Pipeline

Figure 10-10: OncoCyte Corporation - Clinical Pipeline

Figure 10-11: ReNeuron - Clinical Pipeline

Figure 10-12: Sangamo BioSciences - Clinical Pipline

Figure 10-13: Takeda - Clinical Pipeline

Figure 10-14: Vericel – Clinical Pipeline



Table 2-1: Difference between Embryonic, Adult & Induced Stem Cells

Table 3-1: Comparison between Different Types of Stem Cell Transplants

Table 3-2: Few Autologous Stem Cell Therapies under Development

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Cancer Stem Cell Therapy Market Outlook 2020 Report here

News-ID: 1040905 • Views: 186

More Releases from Kuick Resarch

Global Cell Therapy Market To Surpass US$ 35 Billion By 2026
Global cell therapy market is expected to surpass US$ 35 Billion by 2026 as per recent report “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” published by Kuick Research. Increasing investment, gaining research and development activities along with new technological advancement will drive the global cell therapy market. Download Report: https://www.kuickresearch.com/report-global-cell-therapy-market,-clinical-trials,-therapy-price-and-opportunity-insight-2026.php “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” Report Highlights: • Global Cell Therapy
Cell Therapy Market Size Growth Cell Therapy Clinical Trials Market Forecast 202 …
Cell therapies are still in the infancy stages of the clinical development and are expected to evolve in the market with a vast number of opportunities in the healthcare industry. In order to form a stable base for process evaluation and development it will be essential to understand the quality of cell based products. With an increasing number of cell therapies and clinical indications being assessed, it is clear that
Global Cell Therapy Market Size Analysis Clinical Trials Growth Forecast 2026
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
CAR T Cell Therapy Changing The Cancer Oncology Drug Market Landscape
" Global CAR T Cell Therapy Market & Clinical Trials Insight 2024" Report Highlights: • CAR T-Cell Therapies Delivery Pipeline & Mechanism of Action • Sales Analysis of CAR - T Cell Therapy • CAR - T Cell Therapy Market Opportunity: US$ 700 Million • CAR-T Cell Therapies Clinical Pipeline by Company, Indication & Phase: 236 Therapies • CAR-T Cell Therapies in Highest Phase: Preclinical • Marketed CAR-T Cell Therapies: 2 ( Yescarta & Kymriah) • Global Market Scenario of

All 5 Releases


More Releases for Cell

Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect …
Researchmoz added Most up-to-date research on "Global GMP Cell Banking Market By Type - Mammalian Cell, Microbial Cell, Insect Cell and Others" to its huge collection of research reports. This report researches the worldwide GMP Cell Banking market size (value, capacity, production and consumption) in key regions like North America, Europe, Asia Pacific (China, Japan) and other regions. This study categorizes the global GMP Cell Banking breakdown data by manufacturers, region, type
Cell Culture Market Size, Cell Culture Market Share, Cell Culture Market Trends …
According to a new research published by Polaris Market Research the global cell culture market is anticipated to reach more than USD 49 billion by 2026. Cell culture is a rapidly emerging as an implement for analyzing and treating various disease such as Alzheimer’s and cancer. Request for Sample of This Research Report @ https://bit.ly/2D7pZ5u Top Key Players: - Becton, Dickinson and Company Biospherix EMD Millipore Eppendorf AG Merck KGaA Sartorius AG VWR International Cell culture is a rapidly emerging
Cell Therapy Market Cell Therapy Clinical Pipeline Report 2022
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Introduction to Cell Therapy Necessity for Cell Therapy Treatment 2.1 Emergence of Stem Cell Research 2.2 Benefits of Using the Stem Cell for Research and Treatment Application of Stem Cells in Cell Therapy 3.1 Stem Cells Ability to Differentiate 3.1.1 Totipotent Stem Cells 3.1.2 Pluripotent Stem Cells 3.1.3 Multipotent
Global Cell Therapy Market & Cell Therapy Clinical Pipeline Outlook 2022
The cell therapy industry is rapidly growing industry with the several new products that having been accepted for clinical use over the past few years. There are many challenges that need to be resolved wisely before the cell therapies are widely accepted, including the optimization of their manufacture. There is much to be explored about the specific features of the stem cells and about the efficacy and safety of the
Cell Science 2017
It takes us immense pleasure to announce the conference that “Annual Congress on Cell Science, Stem Cell Research & Regenerative Medicine” which is going to be held during November 29-30, 2017 at Atlanta, USA. Cell Science 2017 conference will focus on the latest and exciting innovations in all areas of Cell Biologists and Stem Cell Researchers which offer a unique opportunity for investigators across the globe to meet, network, and perceive
Cell Science 2017
Pulsus Group is an internationally renowned medical peer-review publisher and conferences organizer established in the year 1984 publishes and hosts the work of researchers in a manner that exemplifies the highest standards in research integrity.With a legacy of 30 years of excellence in Medical Publishing we are endorsed by various societies like International Academy of Cardiovascular Sciences, International Society of Addiction Medicine, European Biotechnology Thematic Network Association, World Federation of